Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-07-12 00:00:00 ET · period of report 2024-07-11 · accession 0001968202-24-000107 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-12 | 2024-07-11 | REGN | LAROSA JOSEPH J | EVP GC, Secret | S - Sale | $1,088.95 | -1,866 | 37.9K | -5% | -$2.03M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-11 | S | D | 1,866 | $1,088.95 | 37,937 | D | — | — |